Orlistat

3 trials AGastroenterology

Filter these 3 trials by condition, phase, country and more.

Open in Search →

3 Registered trials

0 Recruiting

3 Completed trials

2 Sponsors

1 Countries

Phase II

Other

Phase II: 2 Other: 1

Indications tested

Sponsors using this IMP

Empros Pharma AB 2 Region Skane 1

All trials

3 total

A PilOt dose-escalation trial with EMP16 in preparation for Phase III – the POEM trial Ended

2024-520122-11-00 Phase II 1 country Empros Pharma AB
Effect of orlistat on LIVER fat content in obese subjects with NAFLD and High concEntrAtion of pLasma proneurotensin THrough inhibition of n… Ended

2022-500366-10-00 Phase II 1 country Region Skane
Control Of BioEquivalence with Xenical (COBEX): A Phase I, randomized, active-control study to evaluate EMP22 pharmacodynamics and EMP16 pha… Ended

2023-505671-74-00 1 country Empros Pharma AB

Showing 1–3 of 3 trials

← All drugs A–Z